© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Jul 25, 2014, the consensus forecast amongst 25 polled investment analysts covering Kalbe Farma Tbk PT advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Dec 07, 2012. The previous consensus forecast advised investors to hold their position in Kalbe Farma Tbk PT.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 15 analysts offering 12 month price targets for
|Div growth (TTM)||-10.53%|
On Apr 30, 2014,
The next earnings announcement is expected on Jul 29, 2014. View Full Interim Financials
|Average growth rate||+2.79%|
|Average growth rate||+21.12%|
PT Kalbe Farma Tbk had 1st quarter 2014 revenues of 4.07bn. This bettered the 4.06bn consensus of the 2 analysts covering the company. This was 10.87% below the prior year's 1st quarter results. View Full Interim Financials
|Average growth rate||+4.38%|
PT Kalbe Farma Tbk had revenues for the full year 2013 of 16.00bn. This was 17.35% above the prior year's results. View Full Annual Financials
|Average growth rate||+15.48%|